STOK
Price
$11.48
Change
-$0.07 (-0.61%)
Updated
Jul 3 closing price
Capitalization
626.77M
38 days until earnings call
TRML
Price
$16.42
Change
+$0.23 (+1.42%)
Updated
Jul 3 closing price
Capitalization
421.8M
Interact to see
Advertisement

STOK vs TRML

Header iconSTOK vs TRML Comparison
Open Charts STOK vs TRMLBanner chart's image
Stoke Therapeutics
Price$11.48
Change-$0.07 (-0.61%)
Volume$185.8K
Capitalization626.77M
Tourmaline Bio
Price$16.42
Change+$0.23 (+1.42%)
Volume$59.09K
Capitalization421.8M
STOK vs TRML Comparison Chart in %
Loading...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STOK vs. TRML commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STOK is a Hold and TRML is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (STOK: $11.48 vs. TRML: $16.42)
Brand notoriety: STOK and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STOK: 30% vs. TRML: 20%
Market capitalization -- STOK: $626.77M vs. TRML: $421.8M
STOK [@Biotechnology] is valued at $626.77M. TRML’s [@Biotechnology] market capitalization is $421.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STOK’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • STOK’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than TRML.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STOK’s TA Score shows that 2 TA indicator(s) are bullish while TRML’s TA Score has 2 bullish TA indicator(s).

  • STOK’s TA Score: 2 bullish, 6 bearish.
  • TRML’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, STOK is a better buy in the short-term than TRML.

Price Growth

STOK (@Biotechnology) experienced а -3.04% price change this week, while TRML (@Biotechnology) price change was -1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

STOK is expected to report earnings on Aug 11, 2025.

TRML is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($627M) has a higher market cap than TRML($422M). STOK YTD gains are higher at: 4.080 vs. TRML (-19.034). STOK has higher annual earnings (EBITDA): 40.3M vs. TRML (-98.41M). STOK has more cash in the bank: 357M vs. TRML (249M). TRML has less debt than STOK: TRML (196K) vs STOK (2.35M). STOK has higher revenues than TRML: STOK (191M) vs TRML (0).
STOKTRMLSTOK / TRML
Capitalization627M422M149%
EBITDA40.3M-98.41M-41%
Gain YTD4.080-19.034-21%
P/E Ratio14.09N/A-
Revenue191M0-
Total Cash357M249M143%
Total Debt2.35M196K1,199%
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STOKTRML
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
86%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASCJF0.14N/A
N/A
AMSC ASA
CHOLF0.77N/A
N/A
China Oilfield Services Ltd.
MGHRX66.37N/A
N/A
Morgan Stanley Inst Growth IR
DBMG41.58N/A
N/A
DBM Global Inc.
HTROF2.70N/A
N/A
HEXATRONIC GROUP AB

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with IMNM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-0.61%
IMNM - STOK
52%
Loosely correlated
+2.43%
NRIX - STOK
52%
Loosely correlated
+2.33%
IDYA - STOK
52%
Loosely correlated
+0.82%
RNA - STOK
50%
Loosely correlated
-0.65%
QTTB - STOK
49%
Loosely correlated
N/A
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+1.42%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
50%
Loosely correlated
+2.43%
STOK - TRML
49%
Loosely correlated
-0.61%
APGE - TRML
45%
Loosely correlated
+7.08%
ANNX - TRML
45%
Loosely correlated
+2.85%
More